[1] Sanchez-de-la-Torre M, Campos-Rodriguez F,Barbe F. Obstructive sleep apnoea and cardiovascular disease[J]. Lancet Respir Med, 2013, 1(1): 61-72.
[2] Peppard PE, Young T, Barnet JH, et al. Increased prevalence of sleep-disordered breathing in adults[J]. Am J Epidemiol, 2013, 177(9): 1006-1014.
[3] Sekizuka H, Osada N,Akashi YJ. Impact of obstructive sleep apnea and hypertension on left ventricular hypertrophy in Japanese patients[J]. Hypertens Res, 2017, 40(5): 477-482.
[4] Patil SP, Ayappa IA, Caples SM, et al. Treatment of adult obstructive sleep apnea with positive airway pressure: an american academy of sleep medicine systematic review, Meta-analysis, and GRADE assessment[J]. J Clin Sleep Med, 2019, 15(2): 301-334.
[5] McEvoy RD, Antic NA, Heeley E, et al. CPAP for prevention of cardiovascular events in obstructive sleep apnea[J]. N Engl J Med, 2016, 375(10): 919-931.
[6] Guan P, Xu BY, Li YQ, et al. Protective effect of astragalus polysaccharides in model rats of doxorubicin induced cardiac injury[J]. Acta Anatomica Sinica, 2013, 44(5): 685-688. (in Chinese)
关鹏, 徐丙元, 李亚青, 等. 黄芪多糖对阿霉素诱导的心力衰竭模型大鼠的保护作用[J]. 解剖学报, 2013, 44(5): 685-688.
[7] Guan P, Lin XM, Yang SC, et al. Hydrogen gas reduces chronic intermittent hypoxia-induced hypertension by inhibiting sympathetic nerve activity and increasing vasodilator responses via the antioxidation[J]. J Cell Biochem, 2019, 120(3): 3998-4008.
[8] Liu T, Yang F, Liu J, et al. Astragaloside Ⅳ reduces cardiomyocyte apoptosis in a murine model of coxsackievirus B3-induced viral myocarditis[J]. Exp Anim, 2019, 68(4): 549-558.
[9] Lin J, Pan X, Huang C, et al. Dual regulation of microglia and neurons by astragaloside Ⅳ-mediated mTORC1 suppression promotes functional recovery after acute spinal cord injury[J]. J Cell Mol Med, 2020, 24(1): 671-685.
[10] Goes CM, Falcochio P,Drager LF. Strategies to manage obstructive sleep apnea to decrease the burden of atrial fibrillation[J]. Expert Rev Cardiovasc Ther, 2018, 16(10): 707-713.
[11] Lee SD, Kuo WW, Wu CH, et al. Effects of short- and long-term hypobaric hypoxia on Bcl-2 family in rat heart[J]. Int J Cardiol, 2006, 108(3): 376-384.
[12] Hang T, Huang Z, Jiang S, et al. Apoptosis in pressure overload-induced cardiac hypertrophy is mediated, in part, by adenine nucleotide translocator-1[J]. Ann Clin Lab Sci, 2006, 36(1): 88-95.
[13] Pialoux Ⅴ, Hanly PJ, Foster GE, et al. Effects of exposure to intermittent hypoxia on oxidative stress and acute hypoxic ventilatory response in humans[J]. Am J Respir Crit Care Med, 2009, 180(10): 1002-1009.
[14] Wang HJ, Tan YZh. Mechanism of autophagy opens a new way for treatment of diseases[J]. Acta Anatomica Sinica, 2017, 48(1): 103-105. (in Chinese)
王海杰,谭玉珍. 细胞自噬机制开启疾病治疗新途径[J]. 解剖学报, 2017, 48(1): 103-105.
[15] Li B, Chi RF, Qin FZ, et al. Distinct changes of myocyte autophagy during myocardial hypertrophy and heart failure: association with oxidative stress[J]. Exp Physiol, 2016, 101(8): 1050-1063.
[16] Hariharan N, Ikeda Y, Hong C, et al. Autophagy plays an essential role in mediating regression of hypertrophy during unloading of the heart[J]. PLoS One, 2013, 8(1): e51632.
[17] McMullen JR, Sherwood MC, Tarnavski O, et al. Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload[J]. Circulation, 2004, 109(24): 3050-3055.
[18] Li L, Xu J, He L, et al. The role of autophagy in cardiac hypertrophy[J]. Acta Biochim Biophys Sin (Shanghai), 2016, 48(6): 491-500.
[19] Rabanal-Ruiz Y, Otten EG,Korolchuk Ⅵ. mTORC1 as the main gateway to autophagy[J]. Essays Biochem, 2017, 61(6): 565-584.
[20] Hahn A, Lauriol J, Thul J, et al. Rapidly progressive hypertrophic cardiomyopathy in an infant with Noonan syndrome with multiple lentigines: palliative treatment with a rapamycin analog[J]. Am J Med Genet A, 2015, 167A(4): 744-751.
|